Background: Over the last decades relevant epidemiological changes of liver diseases have occurred, to-gether with greatly improved treatment opportunities.Aim: To investigate how the indications for elective adult liver transplantation and the underlying disease etiologies have evolved in Italy.Methods: We recruited from the National Transplant Registry a cohort comprising 17,317 adults patients waitlisted for primary liver transplantation from January-2004 to December-2020. Patients were divided into three Eras:1(2004-2011),2(2012-2014) and 3(2015-2020).Results: Waitlistings for cirrhosis decreased from 65.9% in Era 1 to 46.1% in Era 3, while those for HCC increased from 28.7% to 48.7%. Comparing Eras 1 and 3, waitlistings for HCV-related cirrhosis decreased from 35.9% to 12.1%, yet those for HCV-related HCC increased from 8.5% to 26.7%. Waitlistings for HBV-related cirrhosis remained almost unchanged (13.2% and 12.4%), while those for HBV-related HCC in-creased from 4.0% to 11.6%. ALD-related cirrhosis decreased from 16.9% to 12.9% while ALD-related HCC increased from 1.9% to 3.9%.Conclusions: A sharp increase in liver transplant waitlisting for HCC and a concomitant decrease of wait -listing for cirrhosis have occurred In Italy. Despite HCV infection has noticeably decreased, still remains the primary etiology of waitlisting for HCC, while ALD and HBV represent the main causes for cirrhosis. (c) 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Temporal trends of waitlistings for liver transplantation in Italy: The ECALITA (Evolution of IndiCAtion in LIver transplantation in ITAly) registry study / Manzia, Tommaso Maria; Trapani, Silvia; Nardi, Alessandra; Ricci, Andrea; Lenci, Ilaria; Milana, Martina; Angelico, Roberta; De Feo, Tullia Maria; Agnes, Salvatore; Andorno, Enzo; Baccarani, Umberto; Carraro, Amedeo; Cescon, Matteo; Cillo, Umberto; Colledan, Michele; De Carlis, Luciano; De Simone, Paolo; Di Benedetto, Fabrizio; Ettorre, Giuseppe Maria; Gruttadauria, Salvatore; Lupo, Luigi Giovanni; Mazzaferro, Vincenzo; Romagnoli, Renato; Rossi, Giorgio; Rossi, Massimo; Spada, Marco; Vennarecci, Giovanni; Vivarelli, Marco; Zamboni, Fausto; Tisone, Giuseppe; Cardillo, Massimo; Angelico, Mario. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - 54:12(2022), pp. 1664-1671. [10.1016/j.dld.2022.08.033]

Temporal trends of waitlistings for liver transplantation in Italy: The ECALITA (Evolution of IndiCAtion in LIver transplantation in ITAly) registry study

Ricci, Andrea;Rossi, Massimo;Vivarelli, Marco;
2022-01-01

Abstract

Background: Over the last decades relevant epidemiological changes of liver diseases have occurred, to-gether with greatly improved treatment opportunities.Aim: To investigate how the indications for elective adult liver transplantation and the underlying disease etiologies have evolved in Italy.Methods: We recruited from the National Transplant Registry a cohort comprising 17,317 adults patients waitlisted for primary liver transplantation from January-2004 to December-2020. Patients were divided into three Eras:1(2004-2011),2(2012-2014) and 3(2015-2020).Results: Waitlistings for cirrhosis decreased from 65.9% in Era 1 to 46.1% in Era 3, while those for HCC increased from 28.7% to 48.7%. Comparing Eras 1 and 3, waitlistings for HCV-related cirrhosis decreased from 35.9% to 12.1%, yet those for HCV-related HCC increased from 8.5% to 26.7%. Waitlistings for HBV-related cirrhosis remained almost unchanged (13.2% and 12.4%), while those for HBV-related HCC in-creased from 4.0% to 11.6%. ALD-related cirrhosis decreased from 16.9% to 12.9% while ALD-related HCC increased from 1.9% to 3.9%.Conclusions: A sharp increase in liver transplant waitlisting for HCC and a concomitant decrease of wait -listing for cirrhosis have occurred In Italy. Despite HCV infection has noticeably decreased, still remains the primary etiology of waitlisting for HCC, while ALD and HBV represent the main causes for cirrhosis. (c) 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
2022
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/322134
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact